1,515
Views
7
CrossRef citations to date
0
Altmetric
Vaccines

Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis

, , , , &
Pages 1261-1269 | Received 09 Aug 2017, Accepted 08 Dec 2017, Published online: 10 Jan 2018

References

  • Williams WW, Lu PJ, O’Halloran A, et al. Noninfluenza vaccination coverage among adults – United States, 2012. Morb Mortal Wkly Rep 2014;63:95-102
  • Bridges CB, Coyne-Beasley T; Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older – United States, 2014. Morb Mortal Wkly Rep 2014;63:110-12
  • Williams WW, Lu PJ, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations – United States, 2015. Morb Mortal Wkly Rep Surveill Sum 2017;66:1-28
  • Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2008;57:1-30
  • Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older – Advisory Committee on Immunization Practices (ACIP), 2012. Morb Mortal Wkly Rep 2012;61:468-70
  • Hales CM, Harpaz R, Ortega-Sanchez I, et al. Update on recommendations for use of herpes zoster vaccine. Morb Mortal Wkly Rep 2014;63:729-31
  • McGarry LJ, Krishnarajah G, Hill G, et al. Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission. PLoS One 2014;9:e72723
  • McGarry LJ, Krishnarajah G, Hill G, et al. Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly. PLoS One 2013;8:e67260
  • McLaughlin JM, McGinnis JJ, Tan L, et al. Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013. J Prim Prev 2015;36:259-73
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Morb Mortal Wkly Rep 2011;60:13-15
  • Reimbursement for Vaccines and Vaccine Administration Under Medicare Part D. (MLN Matters. no: SE077272013). Baltimore (MD): Centers for Medicare & Medicaid Services, 2013
  • Hurley LP, Lindley MC, Harpaz R, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010;152:555-60
  • Wouters AV, Manthe K, Stone DA. Few Medicare Part D Plans Offer Vaccines Without Cost-Sharing. Available at: https://www.manatt.com/Insights/Newsletters/Health-Update/HIPAA-and-Emerging-Technologies#Article5 [Last accessed 24 October 2017]
  • TransactRx. Simplifying Vaccine Billing. POC Network Technologies Inc. 2014. Available at: http://www.transactrx.com/ [Last accessed 5 January 2015]
  • Stoecker C, Stewart A, Lindley M. Cost of cost-sharing: the impact of Medicaid benefit design on vaccination coverage rates. Abstract presented at: APHA 142nd Annual Meeting & Expo, New Orleans, LA, USA, 15–19 November 2014
  • Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) 2008;27:103-12
  • O’Malley AS, Forrest CB. Immunization disparities in older Americans: determinants and future research needs. Am J Prev Med 2006;31:150-8
  • Schneeberg A, Bettinger JA, McNeil S, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health 2014;14:442
  • Armstrong K, Berlin M, Schwartz JS, et al. Barriers to influenza immunization in a low-income urban population. Am J Prev Med 2001;20:21-5
  • Bridges CB, Hurley LP, Williams WW, et al. Meeting the challenges of immunizing adults. Am J Prev Med 2015;49(6Suppl4):S455-S464
  • Winston CA, Wortley PM, Lees KA. Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc 2006;54:303-10
  • Medicare: Many Factors, Including Administrative Challenges, Affect Access to Part D Vaccinations. (No. GAO-12-61.) U.S. Government Accountability Office, 2011
  • Hurley LP, Bridges CB, Harpaz R, et al. U.S. physicians’ perspective of adult vaccine delivery. Ann Intern Med 2014;160:161
  • Hurley LP, Harpaz R, Daley MF, et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis 2008;197(Suppl2):S216-S223
  • Gozu A, Nidiry MA, Ratanawongsa N, et al. Patient factors associated with following a relocated primary care provider among older adults. Am J Manag Care 2009;15:195-200
  • Nemet GF, Bailey AJ. Distance and healthcare utilization among the rural elderly. Soc Sci Med 2000;50:1197-208
  • Murrin S. State Standards for Access to Care in Medicaid Managed Care. (No. OEI-02-11-00320.) Washington (DC): US Office of Inspector General, Department of Health and Human Services, 2014
  • Yen W. How Long and How Far Do Adults Travel and Will Adults Travel for Primary Care? (Washington State Health Services Research Project, Research Brief no. 70.) Washington (WA): Washington State Office of Financial Management, 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.